| Metric | Q3'25 | Q4'25 | Change |
|---|---|---|---|
| Total Revenue | $214M (-14% YoY) | $238M (-12% YoY) | +11% sequential beat |
| Systems Revenue | $144M | $156M | +8% sequential improvement |
| CS&I Revenue | $70M (record) | $82M (record) | +17% sequential, another record |
| Non-GAAP EPS | $1.21 | $1.49 | +23% sequential beat vs $1.12 guide |
| Non-GAAP Gross Margin | 41.8% | 47.3% | +550bps sequential on favorable mix |
| Bookings | $52M | $128M | +146% sequential recovery |
| Backlog | $484M | $457M | -6% sequential burn |
| China Revenue % | 46% | 32% | -14pts sequential normalization |
| Free Cash Flow | $43M | -$9M | Negative due to December sales timing |
| Full Year Revenue | N/A | $838M (-18% YoY) | Digestion year complete |
Get free previews of our earnings-call research: the key changes, management scores, and questions worth investigating. Subscribe for full call sheets and deeper analysis.
Subscriptions are managed by Substack. If the form does not load, subscribe directly. Or follow the RSS feed.